Institutional Ownership
Vertex Pharmaceuticals Inc
CUSIP 92532F100COMVRTXQ1 2026
Institutional Holders
1,669
13F filers
Shares Held
207.80M
Aggregate institutional
Institutional Value
$90.36B
Q1 2026
Net New Holders
+25
127 new · 102 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions127
Increased676
Decreased588
Sold out102
Institutional Holders
1,669 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Capital World Investors | 25.37M | $11.33B | −142.1K | Reduced |
| 2 | Blackrock, Inc. | 23.97M | $10.70B | +217.5K | Added |
| 3 | Capital Research Global Investors | 21.13M | $9.43B | +3.81M | Added |
| 4 | State Street Corp | 11.73M | $5.24B | +40.6K | Added |
| 5 | Jpmorgan Chase & Co | 7.03M | $3.12B | +993.7K | Added |
| 6 | Geode Capital Management, LLC | 6.14M | $2.73B | +157.7K | Added |
| 7 | Capital International Investors | 5.13M | $2.29B | +392.5K | Added |
| 8 | Loomis Sayles & Co L P | 4.00M | $1.79B | −29.7K | Reduced |
| 9 | Alliancebernstein L.P. | 3.91M | $1.77B | −585.7K | Reduced |
| 10 | Wellington Management Group LLP | 3.21M | $1.43B | −609.1K | Reduced |
1,659 more institutional holders on Premium
See every fund holding Vertex Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders